USA – The FDA has approved ranibizumab 100 mg/mL injection for wet age-related macular degeneration in patients who have previously responded to at least two anti-VEGF injections, according to Genentech.…
Read MoreGenentech’s new continuous release eye treatment gains FDA approval
